Abstract
Since the pioneering discovery of the inhibitory effects of kirromycin on bacterial elongation factor Tu (EF-Tu) more than 25 years ago [1], a great wealth of biological data has accumulated concerning protein biosynthesis inhibitors specific for EF-Tu. With the subsequent discovery of over two dozen naturally occurring EF-Tu inhibitors belonging to four different subclasses, EF-Tu has blossomed into an appealing antimicrobial target for rational drug discovery efforts. Very recently, independent crystal structure determinations of EF-Tu in complex with two potent antibiotics, aurodox and GE2270A, have provided structural explanations for the mode of action of these two compounds, and have set the foundation for the design of inhibitors with higher bioavailability, broader spectra, and greater efficacy.
Keywords: Inhibitory Mechanisms, Antibiotics Targeting Elongation Factor Tu, thermus thermophilus, the kirromycine, pulvomycin, cyclic thiazolyls, enacyloxin lla, planobispora rosea cinnamoneus, nocardialactamdurans, streptomyces, ramocissimus
Current Protein & Peptide Science
Title: Inhibitory Mechanisms of Antibiotics Targeting Elongation Factor Tu
Volume: 3 Issue: 1
Author(s): T. Hogg, J. R. Mesters and R. Hilgenfeld
Affiliation:
Keywords: Inhibitory Mechanisms, Antibiotics Targeting Elongation Factor Tu, thermus thermophilus, the kirromycine, pulvomycin, cyclic thiazolyls, enacyloxin lla, planobispora rosea cinnamoneus, nocardialactamdurans, streptomyces, ramocissimus
Abstract: Since the pioneering discovery of the inhibitory effects of kirromycin on bacterial elongation factor Tu (EF-Tu) more than 25 years ago [1], a great wealth of biological data has accumulated concerning protein biosynthesis inhibitors specific for EF-Tu. With the subsequent discovery of over two dozen naturally occurring EF-Tu inhibitors belonging to four different subclasses, EF-Tu has blossomed into an appealing antimicrobial target for rational drug discovery efforts. Very recently, independent crystal structure determinations of EF-Tu in complex with two potent antibiotics, aurodox and GE2270A, have provided structural explanations for the mode of action of these two compounds, and have set the foundation for the design of inhibitors with higher bioavailability, broader spectra, and greater efficacy.
Export Options
About this article
Cite this article as:
Hogg T., Mesters R. J. and Hilgenfeld R., Inhibitory Mechanisms of Antibiotics Targeting Elongation Factor Tu, Current Protein & Peptide Science 2002; 3 (1) . https://dx.doi.org/10.2174/1389203023380855
DOI https://dx.doi.org/10.2174/1389203023380855 |
Print ISSN 1389-2037 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5550 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Current Treatments of Muco-Cutaneous Herpes Simplex Virus Infections
Current Medicinal Chemistry - Anti-Infective Agents Childhood Psychiatric Disorders in North-India: Prevalence, Incidence and Implications#
Adolescent Psychiatry Distribution of Synthetic Cannabinoids JWH-210, RCS-4 and Δ 9-Tetrahydrocannabinol After Intravenous Administration to Pigs
Current Neuropharmacology Current Methods in the Automatic Tissue Segmentation of 3D Magnetic Resonance Brain Images
Current Medical Imaging Prediction of Conversion from Mild Cognitive Impairment to Alzheimer ’ s Disease by CSF Cytochrome c Levels and N200 Latency
Current Alzheimer Research Homochiral Drug Design and Development by Racemization
Combinatorial Chemistry & High Throughput Screening Biochemical and Therapeutic Effects of Antioxidants in the Treatment of Alzheimers Disease, Parkinsons Disease, and Amyotrophic Lateral Sclerosis
Current Drug Targets - CNS & Neurological Disorders Ca2+ Signaling, Mitochondria and Cell Death
Current Molecular Medicine Kinetic Study on the Effects of Extremely Low Frequency Electromagnetic Field on Catalase, Cytochrome P450 and Inducible Nitric Oxide Synthase in Human HaCaT and THP-1 Cell Lines
CNS & Neurological Disorders - Drug Targets 1,2,4-Triazoles: A Review of Synthetic Approaches and the Biological Activity
Letters in Organic Chemistry Effects of pH on the Association between the Inhibitor Cystatin and the Proteinase Chymopapain
Protein & Peptide Letters Vasopressin and Oxytocin in Control of the Cardiovascular System
Current Neuropharmacology Novel Biomarkers for Lupus Nephritis in the “OMICS” Era
Current Medicinal Chemistry Simultaneous Determination of Paracetamol, Dextromethorphan, Phenylephrine and Chlorpheniramine Using Partial Least Squares
Current Pharmaceutical Analysis MicroRNA Gene Networks in Oncogenesis
Current Genomics CRF Receptor Antagonists: Utility in Research and Clinical Practice
Current Medicinal Chemistry Prediction of the Affinity of the Newly Synthesised Azapirone Derivatives for 5-HT1A Receptors Based on Artificial Neural Network Analysis of Chromatographic Retention Data and Calculation Chemistry Parameters
Combinatorial Chemistry & High Throughput Screening Understanding Stem Cell-Mediated Brain Repair Through Neuroimaging
Current Stem Cell Research & Therapy Maintenance of Gastrointestinal Glucose Homeostasis by the Gut-Brain Axis
Current Protein & Peptide Science Anti-Inflammatory Effects of Physical Activity in Relationship to Improved Cognitive Status in Humans and Mouse Models of Alzheimers Disease
Current Alzheimer Research